Company profile VTRS

Viatris Inc
mylan is a global pharmaceutical company committed to setting new standards in healthcare. working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. we offer a grow...ing portfolio of around 1,400 generic pharmaceuticals and several brand medications. in addition, we offer a wide range of antiretroviral therapies, upon which nearly 50% of hiv/aids patients in developing countries depend. we also operate one of the largest active pharmaceutical ingredient manufacturers and currently market products in about 145 countries and territories. our workforce of approximately 30,000 people is dedicated to creating better health for a better world, one person at a time. learn more at mylan.com. Show More
Quarter analysis & expected interest

There is not enough data for Viatris near me to provide analysis

Correlation between past revenue and Viatris near me search interest

There is not enough data for Viatris near me to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Viatris near me to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Viatris login to provide analysis

Correlation between past revenue and Viatris login search interest

There is not enough data for Viatris login to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Viatris login to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Viatris medications to provide analysis

Correlation between past revenue and Viatris medications search interest

There is not enough data for Viatris medications to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Viatris medications to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Viatris stock quote to provide analysis

Correlation between past revenue and Viatris stock quote search interest

There is not enough data for Viatris stock quote to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Viatris stock quote to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: November 06 2023 12:19:59.

After 34 days of this quarter the interest is at 21.0. Based on that we can calculate that during remaining 58 days it will total up to 57.0.
Viatris stock price expected interest is significantly lower compared to previous quarter (-45.2%) and same quarter last year (-40.6%).

YearQ1Q2Q3Q4
2018 - - - 0
2019 0
0
0
0
2020 0
0
16
inf% YoY inf% QoQ
396
inf% YoY 2375.0% QoQ
2021 479
inf% YoY 21.0% QoQ
357
inf% YoY -25.5% QoQ
297
1756.2% YoY -16.8% QoQ
235
-40.7% YoY -20.9% QoQ
2022 258
-46.1% YoY 9.8% QoQ
164
-54.1% YoY -36.4% QoQ
140
-52.9% YoY -14.6% QoQ
96
-59.1% YoY -31.4% QoQ
2023 118
-54.3% YoY 22.9% QoQ
73
-55.5% YoY -38.1% QoQ
104
-25.7% YoY 42.5% QoQ
21
-78.1% YoY -79.8% QoQ
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Viatris stock price search interestLast update: November 06 2023 12:19:59.
Correlation coefficient between keyword and revenue is 0.46
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: November 06 2023 12:19:59.

The average 5 years interest of Viatris stock price was 10.59 per week.
The last year interest of Viatris stock price compared to the last 5 years has changed by -34.09%.
This is something to be checked.
This didn't exist 5 years ago.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: November 06 2023 12:20:04.

After 34 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 58 days it will total up to 0.0.
Viatris news expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).

YearQ1Q2Q3Q4
2018 - - - 0
2019 0
0
0
0
2020 0
0
0
0
2021 0
0
0
0
2022 54
inf% YoY inf% QoQ
174
inf% YoY 222.2% QoQ
254
inf% YoY 46.0% QoQ
72
inf% YoY -71.7% QoQ
2023 234
333.3% YoY 225.0% QoQ
210
20.7% YoY -10.3% QoQ
191
-24.8% YoY -9.0% QoQ
0
-100.0% YoY -100.0% QoQ
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Viatris news search interestLast update: November 06 2023 12:20:04.
Correlation coefficient between keyword and revenue is -0.49
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: November 06 2023 12:20:04.

The average 5 years interest of Viatris news was 4.57 per week.
The last year interest of Viatris news compared to the last 5 years has changed by 185.34%.
This is something to be checked.
This didn't exist 5 years ago.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Viatris press releases to provide analysis

Correlation between past revenue and Viatris press releases search interest

There is not enough data for Viatris press releases to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Viatris press releases to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: November 06 2023 12:20:43.

After 34 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 58 days it will total up to 0.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
2018 - - - 77
2019 236
206.5% QoQ
151
-36.0% QoQ
77
-49.0% QoQ
43
-44.2% YoY -44.2% QoQ
2020 98
-58.5% YoY 127.9% QoQ
110
-27.2% YoY 12.2% QoQ
0
-100.0% YoY -100.0% QoQ
0
-100.0% YoY -100.0% QoQ
2021 0
-100.0% YoY -100.0% QoQ
0
-100.0% YoY -100.0% QoQ
0
-100.0% YoY -100.0% QoQ
0
-100.0% YoY -100.0% QoQ
2022 0
-100.0% YoY -100.0% QoQ
0
-100.0% YoY -100.0% QoQ
0
-100.0% YoY -100.0% QoQ
0
-100.0% YoY -100.0% QoQ
2023 0
-100.0% YoY -100.0% QoQ
0
-100.0% YoY -100.0% QoQ
0
-100.0% YoY -100.0% QoQ
0
-100.0% YoY -100.0% QoQ
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Viatris products search interestLast update: November 06 2023 12:20:43.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: November 06 2023 12:20:44.

The average 5 years interest of Viatris products was 3.05 per week.
The last year interest of Viatris products compared to the last 5 years has changed by -100.0%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -100.0%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Viatris healthcare. to provide analysis

Correlation between past revenue and Viatris healthcare. search interest

There is not enough data for Viatris healthcare. to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Viatris healthcare. to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for VTRS
Earnings date: 2024-02-28 After close
Company name: Viatris Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-05-08T18:18:50Z

Analyst Upgrades
JP Morgan Maintains Neutral on Viatris, Raises Price Target to $18

2026-05-08T17:31:42Z

Analyst Upgrades
Truist Securities Maintains Buy on Viatris, Raises Price Target to $20

2026-05-07T16:30:00-04:00

PR Newswire
Viatris to Present at the Bank of America Securities 2026 Healthcare Conference

2026-05-07T06:59:00-04:00

PR Newswire
Viatris Reports First-Quarter 2026 Financial Results

2026-05-05T06:59:00-04:00

PR Newswire
Viatris Announces Quarterly Dividend

2026-05-04T16:30:00-04:00

PR Newswire
Viatris Announces Chief Financial Officer Transition

2026-05-01T06:59:00-04:00

PR Newswire
Viatris Announces Several Data Presentations on Investigational Low-Dose Estrogen Combined Hormonal Contraceptive Weekly Patch at the 2026 American College of Obstetricians and Gynecologists Annual Clinical & Scientific Meeting

2026-04-13T06:59:00-04:00

PR Newswire
Viatris to Report First Quarter 2026 Financial Results on May 7, 2026

2026-04-10T06:59:00-04:00

PR Newswire
Viatris Announces Multiple Data Presentations at the 2026 American Society of Cataract and Refractive Surgery Annual Meeting

2026-03-31T11:51:40Z

Analyst Upgrades
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields

2026-03-24T14:10:54Z

Analyst Upgrades
Barclays Maintains Overweight on Viatris, Raises Price Target to $17

2026-03-23T06:59:00-04:00

PR Newswire
Viatris Advances Innovative Portfolio with Approval of Effexor® in Japan for Adults with Generalized Anxiety Disorder (GAD)

2026-03-19T08:30:00-04:00

PR Newswire
Viatris to Outline its Vision for Sustained Revenue and Earnings Growth Through 2030

2026-02-26T06:59:00-05:00

PR Newswire
Viatris Reports Fourth-Quarter and Full-Year 2025 Financial Results

2026-02-26T06:55:00-05:00

PR Newswire
Viatris Maintains Dividend Policy for 2026 and Announces Quarterly Dividend